Development of Lipid-Polymer combined Oral micelles for Enhanced Oral Delivery of Lovastatin
Lovastatin is a Biopharmaceutics Classification System (BCS) Class II drug characterized by poor aqueous solubility and limited oral bioavailability, resulting in variable therapeutic performance. The present study aimed to develop, optimize, and evaluate lovastatin-loaded nanoparticulate carriers for enhancing solubil...